AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody, for the treatment of pyoderma gangrenosum (PG). Humira was granted ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...
Will 3D Printing Revolutionize Orthopedic Implant Surgery? Or is it a high-tech, high-cost solution in search of a problem? Dr Timothy Wright talks about the potential of additive manufacturing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback